Key result
A patient with massive Ewing's sarcoma of the right femur and distant metastasis treated with chemotherapy succumbed to his illness before completion of therapy.
Case Report (n=1)
Ewing's sarcoma with distant metastasis carries a poor prognosis, highlighting the need for integrating novel molecular targets with conventional chemotherapy.
Answers are grounded in this paper and cite their sources.
Reinforces poor prognosis of metastatic Ewing's sarcoma despite chemotherapy; leaves open need for novel therapies in research.
Ewing's sarcoma is an aggressive fatal malignancy of bones and soft-tissue. It predominantly affects the young population, with a worldwide incidence of three cases per million. The pelvis, extremities, and ribs are the most common sites. We present a case of massive Ewing's sarcoma of the right femur with metastasis to bones and lungs. The patient was treated with chemotherapy. However, he succumbed to his illness before completion of therapy. In conclusion, Ewing's sarcoma with distant metastasis is a high risk case with poor prognosis. Integrating novel molecular targets with conventional chemotherapeutic agents holds a promise for high-risk Ewing's sarcoma patients.
No takes yet. Share an insight, caveat, or question.
Meshram et al. (2019) conducted a case report in Ewing's sarcoma with distant metastasis (n=1). Chemotherapy was evaluated on Survival. A patient with massive Ewing's sarcoma of the right femur and distant metastasis treated with chemotherapy succumbed to his illness before completion of therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: